In an open-label clinical study pramlintide lowered A1C, body weight, and insulin use in patients with type 1 diabetes failing to achieve glycemic targets with insulin therapy

被引：0
|
作者：
Guthrie, R
Karl, DM
Wang, Y
Lorenzi, G
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A118 / A118
页数：1
相关论文
共 50 条
  • [31] Patients with type 2 diabetes can achieve A1C targets with once-daily biphasic insulin aspart 70/30 before supper
    Jain, R
    Wahl, T
    Wahlen, J
    Bressler, P
    Hu, P
    Allen, E
    [J]. DIABETES, 2004, 53 : A130 - A130
  • [32] Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: Results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart
    Tamborlane, William V.
    Renard, Eric
    Wadwa, R. Paul
    Blevins, Thomas
    Jacober, Scott J.
    Liu, Rong
    D'Souza, Deborah N.
    Rees, Tina M.
    [J]. JOURNAL OF DIABETES, 2015, 7 (02) : 270 - 278
  • [33] Predictive Value of Admission Hemoglobin A1c on Inpatient Glycemic Control and Response to Insulin Therapy in Medicine and Surgery Patients With Type 2 Diabetes
    Pasquel, Francisco J.
    Gomez-Huelgas, Ricardo
    Anzola, Isabel
    Oyedokun, Festus
    Haw, J. Sonya
    Vellanki, Priyathama
    Peng, Limin
    Umpierrez, Guillermo E.
    [J]. DIABETES CARE, 2015, 38 (12) : E202 - E203
  • [34] Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets
    Kolterman, O
    Maggs, D
    Fineman, M
    Burrell, T
    Strobel, S
    Shen, L
    Weyer, C
    [J]. DIABETOLOGIA, 2002, 45 : A240 - A240
  • [35] Advanced Insulin Management program reduces A1C and regimen distress without weight gain in patients with type 1 diabetes
    Fish, Lisa H.
    Anderson, Robyn L.
    Moore, Amy L.
    Perron, Shannon M.
    Wintheiser, Ann L.
    Davidson, Janet L.
    [J]. DIABETES, 2006, 55 : A30 - A30
  • [36] Metformin adjunctive therapy with insulin improves glycemic control in patients with type 1 diabetes: A pilot study
    Gomez, R
    Rao, J
    Vargas, A
    Compton, T
    McCarter, R
    Chalew, S
    [J]. DIABETES, 2000, 49 : A358 - A358
  • [37] Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets
    Ratner, R
    Whitehouse, F
    Fineman, MS
    Strobel, S
    Shen, L
    Maggs, DG
    Kolterman, OG
    Weyer, C
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (04) : 199 - 204
  • [38] Timing of Meal Insulin Boluses to Achieve Optimal Postprandial Glycemic Control in Patients with Type 1 Diabetes
    Cobry, Erin
    McFann, Kim
    Messer, Laurel
    Gage, Victoria
    VanderWel, Brandon
    Horton, Lauren
    Chase, H. Peter
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 (03) : 173 - 177
  • [39] Effects of pramlintide therapy: A 1-year study in insulin-requiring type 2 diabetes
    Ratner, R
    Levetan, C
    Schoenfeld, S
    Jeffcoate, S
    Kolterman, O
    [J]. DIABETOLOGIA, 1998, 41 : A61 - A61
  • [40] In type 1 diabetes, addition of pramlintide to insulin therapy resulted in long-term glycemic improvement without the increase in severe hypoglycemia noted in patients treated with insulin alone
    Maggs, DG
    Fineman, MS
    Burrell, TA
    Gottleib, AB
    Kolterman, OG
    [J]. DIABETES, 2001, 50 : A442 - A442
12345